<?xml version="1.0" encoding="UTF-8"?>
<p>On the basis of its ADME profile, oseltamivir shows overall good bioavailability for a drug intended for oral administration. It was previously shown that oseltamivir has an 80% bioavailability upon oral administration and a limited potential for clinically relevant interactions with commonly co-administered drugs [
 <xref rid="B122-jcm-09-02084" ref-type="bibr">122</xref>]. Given its structure and metabolic pathway, oseltamivir does not contain known toxicophore groups or precursors.
</p>
